Johnson & Johnson Boosts U.S. Investments to $55B
Expansion Amid Tariff Threats Johnson & Johnson (JNJ.N) announced plans to increase its U.S. investments by 25% to more than $55 billion over the next four years. The move comes as the
Pfizer CEO Discusses Impact of Trump’s Pharmaceutical Tariffs
Pfizer CEO Albert Bourla voiced concerns on Tuesday about the uncertainty surrounding President Donald Trump’s planned pharmaceutical tariffs, which are deterring the company from increasing investments in U.S. manufacturing and research and
